Tilray Brands (TLRY)
(Delayed Data from NSDQ)
$1.98 USD
-0.14 (-6.60%)
Updated May 17, 2024 04:00 PM ET
After-Market: $2.01 +0.03 (1.52%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Brokerage Reports
Tilray Brands, Inc. [TLRY]
Reports for Purchase
Showing records 141 - 160 ( 219 total )
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Canadian LPs: Mixed Outlook with Regulatory, Limited Retail, and 2.0 Overhangs
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Canada Industry Overhangs Continue, Lowering Estimates and Outlook
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Receives GMP Certification at EU Campus, Allows for International Export
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
3Q19 Strong Revenue Results, Nearing an Inflection
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S